HEM Pharma Inc.

376270· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩43,850+8.00%

2026-08-04

Financials

Valuation Metrics

HEM Pharma Inc.'s Market Cap is ₩3166B. At end of 2025 it was ₩3310B. Ranked #616 of 2,436 in KR market (top 25%), #245 of 1,649 on KOSDAQ (top 15%), #68 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 29%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	316.56B KRW	KR#616/2,436 Sec#68/234
Revenue	14.41B KRW	KR#2,218/2,436 Sec#166/234
Net Income	-25.43B KRW	KR—/2,436 Sec—/234
Total Assets	52.81B KRW	KR#2,164/2,436 Sec#194/234
Net Assets	1.73B KRW	KR#2,392/2,436 Sec#230/234
Employees	86	KR#1,741/2,436 Sec#137/234
Value
P/B	182.65x	KR#2,407/2,436 Sec#230/234
P/S	21.96x	KR#2,335/2,436 Sec#183/234
FCF Yield	-5.72%	KR—/2,436 Sec—/234
Profitability
ROA	-48.16%	KR#2,352/2,436 Sec#218/234
Op. Margin	-118.40%	KR#2,323/2,436 Sec#178/234
Revenue Growth	40.83%	KR#364/2,436 Sec#33/234
Financial Health
Debt Ratio	3047.34%	KR#2,392/2,436 Sec#230/234
Total Debt	17.47B KRW	KR#1,405/2,436 Sec#117/234
FCF	-18.10B KRW	KR#1,880/2,436 Sec#177/234
Cash	12.47B KRW	KR#1,536/2,436 Sec#116/234
Current Ratio	0.48x	KR#2,262/2,436 Sec#216/234
Performance
1Y Return	140.27%	KR#84/2,436 Sec#6/234
1M Return	5.79%	KR#823/2,436 Sec#65/234
From 52W High	-55.03%	KR#1,515/2,436 Sec#125/234
1Y MDD	-62.82%	KR#1,576/2,436 Sec#126/234
Trading
Volume	7,989 shares	KR#2,101/2,436 Sec#207/234
Foreign Own.	0.56%	KR—/2,436 Sec—/234
Per Share
EPS	-3,608 KRW	KR—/2,436 Sec—/234
BPS	202 KRW	KR#2,427/2,436 Sec#234/234

Company Info

CEO 지요셉

Employees 86

Founded 2016

HQ 경기도 수원시, KR

Website www.hempharma.bio

동사는 2016년 물리·화학·생물학 연구개발업을 목적으로 설립되었으며, 2024년 11월 코스닥시장에 기술성장기업으로 상장함. 2025년 1분기 일본 도쿄에 해외법인 HEM Pharma Japan을 설립하였고, 4월 로그미를 인수하여 자회사로 편입함. 장내미생물 시뮬레이션 기술인 PMAS를 활용한 맞춤형 헬스케어 사업과 LBP 디스커버리 플랫폼 사업을 영위하는 글로벌 마이크로바이옴 전문 헬스케어 기업임. HEM파마는 2016년에 설립되었으며 경기도 수원시에 본사를 두고 있습니다.